crystallization screen solution procomplex screen (Qiagen)
90
Structured Review
Qiagen
crystallization screen solution procomplex screen
Crystallization Screen Solution Procomplex Screen, supplied by Qiagen, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/crystallization+screen+solution+procomplex+screen/crystallization+screen+solution+procomplex+screen/pm39360636-201-22-27
Average 90 stars, based on 1 article reviews
Crystallization Screen Solution Procomplex Screen, supplied by Qiagen, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/crystallization+screen+solution+procomplex+screen/crystallization+screen+solution+procomplex+screen/pm39360636-201-22-27
Average 90 stars, based on 1 article reviews
crystallization screen solution procomplex screen - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
Crystallization Assay:Article Title: Structure-Guided Discovery of cis -Hexahydro-pyrido-oxazinones as Reversible, Drug-like Monoacylglycerol Lipase Inhibitors. Article Snippet: Monoacylglycerol lipase (MAGL) is a key enzyme involved in the metabolism of the endogenous signaling ligand 2arachidonoylglycerol, a neuroprotective endocannabinoid intimately linked to central nervous system (CNS) disorders associated with neuroinflammation.. In the quest for novel MAGL inhibitors, a focused screening approach on a Roche library subset provided a reversible benzoxazinone hit exhibiting high ligand efficiency.. The subsequent design of the three-dimensional cis-hexahydro-pyrido-oxazinone (cisHHPO) moiety as benzoxazinone replacement enabled the combination of high MAGL potency with favorable ADME properties. Diffusion-based Assay:Article Title: Structure-Guided Discovery of cis -Hexahydro-pyrido-oxazinones as Reversible, Drug-like Monoacylglycerol Lipase Inhibitors. Article Snippet: Monoacylglycerol lipase (MAGL) is a key enzyme involved in the metabolism of the endogenous signaling ligand 2arachidonoylglycerol, a neuroprotective endocannabinoid intimately linked to central nervous system (CNS) disorders associated with neuroinflammation.. In the quest for novel MAGL inhibitors, a focused screening approach on a Roche library subset provided a reversible benzoxazinone hit exhibiting high ligand efficiency.. The subsequent design of the three-dimensional cis-hexahydro-pyrido-oxazinone (cisHHPO) moiety as benzoxazinone replacement enabled the combination of high MAGL potency with favorable ADME properties. |